b>j)΄!Pԫ&;"kB޶}pSVT(wę!j x;-m@JnQ+պכ7MajfJͱ4jѲ撆RxZMz7vIW/dٞТזcZM~ji ߒsQzԠDW3Den"M+/B:-uIJ7j委9p='mANޭ=/B:-n&nUfqxZM~c Ϲ+,&ᾺܢF[(1*" ϒ"Jԧ<;b" "jܢF[x ,!q қ*]/؝27SMcs"ޭDQ/应ܢF_! :s" 7`F+SVTn"IJnQ/应B 4 wD"IJ׭-`S9DrjiEJ߅gJ应矁[xZM~n"IB؃!'Тѕ+(mIKʭ/|ϐܢF[xZMzG %嬩/c[[\n

Salofalk contains the active substance mesalazine (also known as mesalamine), which belongs to a group of medicines called aminosalicylates. These medicines are designed to reduce inflammation directly at the intestinal lining.<\/p>\n

Salofalk tablets are used for the treatment of acute episodes of mild to moderate ulcerative colitis, a chronic inflammatory disease affecting the colon.<\/p>\n

Salofalk may be prescribed for the following therapeutic purposes:<\/b><\/p>\n